SWTXSpringWorks Therapeutics, Inc.

Nasdaq springworkstx.com


$ 44.89 $ 0.07 (0.16 %)    

Friday, 17-May-2024 15:59:59 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 44.84
$ 44.65
$ 0.00 x 0
$ 0.00 x 0
$ 43.87 - $ 44.89
$ 18.00 - $ 53.92
630,433
na
3.31B
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-springworks-therapeutics-maintains-74-price-target

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

 springworks-therapeutics-q1-2024-gaap-eps-118-misses-116-estimate-sales-21006m-beat-12206m-estimate

SpringWorks Therapeutics (NASDAQ:SWTX) reported quarterly losses of $(1.18) per share which missed the analyst consensus estima...

 hc-wainwright--co-maintains-buy-on-springworks-therapeutics-raises-price-target-to-74

HC Wainwright & Co. analyst Robert Burns maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and raises the pric...

 jp-morgan-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-74

JP Morgan analyst Anupam Rama maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

 barclays-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-63

Barclays analyst Peter Lawson maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

 wedbush-maintains-outperform-on-springworks-therapeutics-raises-price-target-to-70

Wedbush analyst David Nierengarten maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Outperform and raises the price t...

 barclays-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-47

Barclays analyst Peter Lawson maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

 why-springworks-therapeutics-stock-swtx-is-nosediving

SpringWorks Therapeutics Inc (NASDAQ: SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announ...

 springworks-therapeutics-prices-upsized-public-offering-of-9482758-common-shares-at-29share

The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, ...

 springworks-therapeutics-commences-public-offering-of-250m-of-shares-of-its-common-stock

In addition, SpringWorks expects to grant the underwriters a 30-day option to purchase up to an additional $37.5 million of sha...

 why-titan-machinery-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

 la-z-boy-posts-upbeat-earnings-joins-victorias-secret-snowflake-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.

 goldman-sachs-maintains-buy-on-springworks-therapeutics-raises-price-target-to-52

Goldman Sachs analyst Corinne Jenkins maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and raises the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION